Drug Discovery - Medicine.net

High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds

byRadboud UniversityScanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAIDA higher dose of the antibiotic rifampicin does not improve survival rates for pat

Updated on: January 23,2026

High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds

byRadboud UniversityScanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAIDA higher dose of the antibiotic rifampicin does not improve survival rates for pat

Updated on:January 23,2026

Global use of antiseizure drug linked to birth defects is on the rise

Updated on: December 18,2025

Global use of antiseizure drug linked to birth defects is on the rise

Updated on:December 18,2025

$FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma$

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme

Updated on: December 27,2025

$FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma$

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme

Updated on:December 27,2025

Combo pill boosts heart function, symptoms, life quality

Updated on: December 16,2025

Combo pill boosts heart function, symptoms, life quality

Updated on:December 16,2025

What happens when you donate your brain to science?

Updated on: December 23,2025

What happens when you donate your brain to science?

Updated on:December 23,2025

FDA approves oral Nuzolvence and Blujepa for treating uncomplicated gonorrhea

by Lori SolomonThe U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection gonorrhea.The first approval is forNuzolvence(zoliflodacin) gr

Updated on: January 13,2026

FDA approves oral Nuzolvence and Blujepa for treating uncomplicated gonorrhea

by Lori SolomonThe U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection gonorrhea.The first approval is forNuzolvence(zoliflodacin) gr

Updated on:January 13,2026